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STUDY PROTOCOL Open Access
Treating anxiety after stroke (TASK): the
feasibility phase of a novel web-enabled
randomised controlled trial
Ho-Yan Yvonne Chun* , Alan J. Carson, Martin S. Dennis, Gillian E. Mead and William N. Whiteley
Abstract
Background: Anxiety affects a quarter of strokes. It can be disabling even after mild stroke and transient ischaemic
attack (TIA). It is not feasible to deliver conventional psychological therapies to the large population of anxious
stroke and TIA patients. We are testing the feasibility of a web-enabled randomised controlled trial (RCT) to
compare an individualised telemedicine cognitive behavioural therapy (CBT)-based intervention with a self-
guided web-based relaxation programme. This study aims to evaluate the feasibility of novel trial procedures
and the delivery of the TASK interventions in stroke and TIA patients.
Methods: We aim to recruit 40 community-based stroke and TIA patients experiencing anxiety at least 1 month
post-discharge in Lothian, Scotland. We will assess the (1) recruitment number per month; (2) percentage completion
of electronic consent; (3) time taken for remote eligibility confirmation; (4) percentage completion of follow-up surveys:
modified Rankin scale, EuroQol-5D5L, 7-item generalised anxiety disorder, Patient Health Questionnaire-2 and modified
fear questionnaire; (5) data capture of intervention fidelity and (6) use of actigraph smartwatches to obtain continuous
data of rest/activity.
Discussion: The current study will provide feasibility data on streamlined web-enabled trial procedures and the use of
smartwatches to obtain objective measures in stroke and TIA patients, offering potential for large efficient RCTs to be
conducted centrally and remotely with far fewer resources in the future. This study will inform further refinements of
the TASK interventions before evaluation in a definitive RCT.
Trial registration: Clinicaltrials.gov NCT03439813. Retrospectively registered on 20/2/2018.
Keywords: Telemedicine, Web-enabled, Cognitive behavioural therapy, Stroke, Anxiety, Wearable
Background
There are more than 100,000 strokes per year and 1.2
million stroke survivors in the UK [1]. Anxiety affects a
quarter of stroke patients [2], equivalent to around
25,000 patients per year. Anxiety is associated with de-
pendence, poorer quality of life and restricted participa-
tion in work and social activities after even mild stroke
and TIA [3].
Phobic and generalised anxiety
Anxiety is a universal emotion that helps people adapt to
changing situations. However, it can become maladaptive
when anxiety becomes pervasive or out-of-proportion to
the danger posed by a situation. When maladaptive anxiety
starts to interfere with a person’s occupational or social
functioning, it is considered an anxiety disorder. Anxiety
can be broadly divided into two clinical subtypes—phobic
and generalised. Phobic anxiety is characterised by a dispro-
portionate fear of well-defined situations or stimuli and
marked avoidance of those situations [4]. By contrast, gen-
eralised anxiety disorder is diffuse and unremitting, charac-
terised by persistent and multiple worries, e.g. finances,
health and an inability to stop worrying [4]. In our recent
prospective cohort, we found phobic disorder to be the pre-
dominant anxiety subtype after stroke and TIA [3].
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What are stroke patients anxious about?
Patients with anxiety disorder reported more avoidance
in agoraphobia-related situations, e.g. going out alone,
going to crowded places and travelling on public trans-
port; social situations and specific situations, e.g. phys-
ical exertion, having sex, being alone at home and
activities related to fear of having a headache, another
stroke or a fall [3]. In our recent study, we found that
the fear of stroke recurrence is the most commonly re-
ported anxiety-provoking thought post stroke/TIA. This
fear appeared to have led to differential behaviours in
our patients. In some, this anticipatory anxiety brought
about a desire for better health and increased positive
health behaviours, e.g. complying with medications and
doctor’s advice on lifestyle, while others developed a
grossly distorted view of their risk of stroke recurrence
despite adhering to secondary prevention [3]. These pa-
tients feared having a debilitating stroke on a regular
basis, perpetuating maladaptive avoidance of daily situa-
tions. Both avoidant behaviours and distorted thinking
are targets for a CBT-based intervention.
Predictors for anxiety after stroke/TIA
Younger people and those with a previous history of anx-
iety or depression are more likely to develop anxiety after
stroke [3, 5]. Longitudinal data suggested anxiety post
stroke could last up to 10 years [6].
Barriers to accessing CBT in stroke and TIA
Inadequate service provision in psychological care post
stroke across the UK is evident from the reports of the
Sentinel Stroke National Audit Programme in England,
Wales and Northern Ireland [7] and the latest Royal
College of Physicians Stroke Guideline [8]. The de-
mand for better access to psychological care post
stroke has consistently been echoed by surveys and
qualitative research of patients, carers and health pro-
fessionals, and through charitable organisations repre-
senting stroke patients [9–11]. Delivering CBT in a
conventional face-to-face format to all patients with
anxiety post stroke/TIA is not feasible in clinical prac-
tice given the high prevalence of anxiety in this popu-
lation and limited resources. In Scotland alone, a
quarter of stroke patients equate to 2000–3000 pa-
tients per year. Our stakeholder activity involving the
clinical leads of stroke and clinical psychology services
from across Scotland (Additional file 1) agreed that
this demand was unlikely to be met by primary care
providers alone, nor the traditional paradigm of refer-
ring patients for face-to-face psychotherapy delivered
by highly-trained specialists. The shortage of highly
trained staff and geographical variation was unlikely to
be resolved in the near future.
Other potential barriers to accessing psychological
therapy include the inability to attend face-to-face
appointments due to physical immobility and social
stigma attached to seeking psychological treatment. Re-
luctance to travel in agoraphobia and the fear of being
judged in social phobia are diagnosis-specific barriers to
attending face-to-face sessions. People with social phobia
symptoms were three times more likely to report a fear
of what others might think or say about them if they
sought psychological treatment compared to people with
other anxiety disorders [12]. To date, randomised con-
trolled trials (RCT) of guided internet-delivered CBT for
anxiety and depressive disorder in general adults have
shown good patient adherence and satisfaction [13].
Potential of a telemedicine CBT-based intervention
Telemedicine could offer a way to overcome the bar-
riers in accessing psychological therapy by treating
patients remotely while maintaining an individualised
therapist-patient alliance that is integral to CBT. Meta
-analyses demonstrated guided internet-based CBT to
be superior to waitlist control and as efficacious as
face-to-face CBT in treating anxiety disorders or de-
pression in general adults, with face-to-face CBT
spending seven times more therapist time than guided
internet-based CBT [13, 14]. It is not yet certain
whether these findings could be generalised to stroke
and TIA patients, who tend to be older, have neuro-
logical deficits and medical co-morbidities. The effect
of such interventions on patient outcomes after
stroke/TIA needs to be evaluated in RCTs.
Delivering CBT remotely via telemedicine would en-
able centralisation of resources for staff, training, quality
monitoring and cross-covering of different geographical
areas, reducing travel time for therapists as well as pa-
tients. Digital content and treatment approaches in a
telemedicine intervention could be updated and refined
easily, thus, making use of the latest best evidence. The
provision, maintenance and updating of digital content
could be commissioned or delivered via charitable orga-
nisations. Organisation delivering the intervention can
continue to invest in research and development to utilise
the latest technology to deliver the treatment content at
lower costs. At present, it is not yet clear whether
telemedicine-delivered CBT is cost effective in stroke
and TIA patients.
TASK intervention development
We developed the treating anxiety after stroke
(TASK) CBT intervention following the UK Medical
Research Council’s framework for complex interven-
tion development [15], elaborated by the Six essential
Steps in Quality Intervention Development (6SQUiD)
[16]—a formal methodology using a systematic, logical
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and evidence-based approach for complex interven-
tion development. Using this approach, we employed
existing research findings, our original research and
stakeholders’ activities in developing TASK-CBT, re-
ported in detail in Additional files 1 and 2. We mod-
elled the processes and outcomes of the TASK-CBT
intervention in a logic diagram in Fig. 1. Our current
study represents the process evaluation and feasibility
testing in a small scale before TASK-CBT can be eval-
uated in a definitive RCT.
Conducting an RCT entirely remotely by applying
information technology
A definitive RCT needs to recruit and retain large num-
ber of patients to provide sufficient power to detect a
clinically relevant treatment effect. Web-enabled and au-
tomated trial procedures can centralise processes and re-
sources, offering the potential for scaling up an RCT
with far fewer resources and costs than conventional
procedures. For instance, one of the major costs of trad-
itional multicentre trials is the setting up of multiple
centres which includes establishing legal contract be-
tween the sponsor and local sites, identification and
training of local staff, site initiation visits, monitoring,
local closeout and archiving. Adopting a novel centra-
lised system could avoid the need for these and stream-
line a large trial. Feasibility of remotely performed trial
procedures need to be tested in stroke and TIA patients:
online self-screening and recruitment, remote eligibility
confirmation, electronic informed consent, remote inter-
vention delivery, automated self-reported outcome mea-
sures and data capture of intervention fidelity.
Use of smartwatches to collect continuous data on
activity/rest in an RCT
Anxious patients after stroke showed higher levels of
avoidant behaviour across a range of situations, e.g. go-
ing out alone, physical exertion and social situations
Fig. 1 Modelling processes and outcomes of TASK-CBT
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compared with those who were not anxious [3]. Dis-
turbed sleep is a feature common to both anxiety and
depression. RCTs of psychological interventions have
conventionally relied on self-reported outcomes using
questionnaires. This requires effort from participants.
Non-responders (attrition) can bias results and reduce
the power of the study, resulting in a waste of valuable
research resources. A wrist-worn smartwatch that re-
cords actigraphy (non-invasive method of monitoring
rest/activity cycles) continuously could provide data on
activity and sleep, offering the potential of measuring
objective outcomes throughout the entire RCT with
minimal patient effort. The feasibility of long-term con-
tinuous monitoring using this method has not previously
been tested in RCTs of psychological intervention or
RCTs of stroke/TIA patients [17]. The requirement for
participants to return smartwatches during an RCT
could pose an attrition issue which we will explore in
the current study.
Objectives
This study aims to evaluate the feasibility of (i) novel
web-enabled trial procedures, (ii) the TASK-CBT
intervention and (iii) actigraph smartwatches to collect
continuous data throughout the entire trial in stroke/TIA
patients.
Methods
We report the protocol of the TASK feasibility RCT in ac-
cordance with the SPIRIT checklist [18] Additional file 3).
Description of TASK-CBT adheres to items on the TiDier
(template for intervention description and replication)
checklist [19] (Additional file 4). The trial protocol is reg-
istered at ClinicalTrials.gov (NCT03439813).
Trial design
The TASK feasibility trial is a parallel two-armed RCT
comparing TASK-CBT with TASK-Relax. Figure 2 illus-
trates the participant timeline in a schematic.
Information technology used in the design of the TASK
feasibility RCT
We designed the TASK trial procedures using Research
Electronic Data Capture (REDCap), a secure web-based
database management application [20]. We created three
Fig. 2 TASK feasibility trial schematic
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websites, one for recruitment (www.task4stroke.org) [21],
one for the TASK-CBT intervention and one for the com-
parator TASK-Relax using an industry-led website builder.
Using REDCap, we embedded data collection forms in
our websites for self-screening for eligibility, informed
consent and online tasks for TASK-CBT. Usage of all web-
sites is monitored with Google Analytics. In our smart-
watch sub study, we are testing the feasibility of
GENEActiv Original smartwatch [22], a device designed
primarily for research with validation data [22]. Continu-
ous data (triaxial accelerometry, temperature, light) are re-
corded and can be downloaded from each device for
analysis of physical activity and sleep. No data are stored
on a commercial ‘cloud’, and no patient identifiable data
are stored on the device.
Patient population—inclusion and exclusion criteria
We aim to recruit 40 community-based residents within
NHS Lothian (United Kingdom postcodes EH and FK1)
who are aged 18 or above, with a diagnosis of stroke or
TIA (probable, definite or ocular), at least 1 month after
being discharged to the community from clinic or hos-
pital ward. Participants need to have capacity to give in-
formed consent, be able to communicate in English on
the telephone, have internet access and report at least
one positive response on our 6-item anxiety screening
questions (Additional file 5). These items were derived
from the GAD-7 [23] and modified fear questionnaire
[3, 5] using psychometric techniques including factor
analysis, analysis of internal consistency and Mokken
scaling [Chun, H.-Y.Y., et al. Deriving the 6-item anxiety
screening questions for a randomised controlled trial in
stroke. Unpublished 2018].
We exclude people already taking part in a clinical
trial of treatment intended to improve psychosocial out-
comes post stroke.
Recruitment methods
The TASK recruitment website: www.task4stroke.org
[21] is publically accessible, where participant informa-
tion is available via a video or a readable format. Inter-
ested potential participants can complete the ‘Sign Up
and Consent Form’ on the website. We disseminate the
website address as widely as possible amongst patients,
community stroke nurses, stroke physicians, stroke re-
habilitation therapists and stroke charities using printed
‘business cards’, flyers and social media. We offer trial in-
formation to stroke and TIA patients during their
one-month telephone follow-up by a stroke clinician as
part of routine stroke care. In addition, we sent postal
invitations to eligible participants identified from the
NHS Lothian stroke audit registry retrospectively.
On receiving the completed ‘Sign Up and Consent
Form’, the TASK research team verifies the eligibility and
identity of the potential participant using electronic health
records and over the telephone with the participant within
five working days. Baseline data are immediately collected
at this point (T0), followed by randomisation.
Intervention and comparator
We designed the TASK-CBT intervention to be deliv-
ered via telemedicine—telephone, website, email and
mobile text. This enables remote delivery of the inter-
vention while preserving the individualised therapeutic
alliance between the therapist and the patient that is in-
tegral to CBT. The TASK-CBT intervention represents a
low-intensity, guided self-help psychological intervention
in a stepped care model [24]. A health professional with
experience working with stroke patients, e.g. stroke
nurse, stroke physician delivers TASK-CBT under the
supervision of a specialist, e.g. psychiatrist or clinical
psychologist.
Delivery of ‘active ingredients’ of TASK-CBT by telephone
and web
We summarise the key ‘active ingredients’ of the
TASK-CBT intervention in Fig. 3. In brief, the TASK
therapist delivers a course of six individualised telephone
CBT sessions, 35–45 min each, at least 1 week apart,
with the use of an electronic TASK therapist’s manual
and record. Each session is supplemented by the pre-
scription of an online task and one or more of the psy-
choeducational videos on the TASK-CBT treatment
website. To encourage adherence, we send a mobile text
to remind participant to complete the online task each
week and to use the treatment website as much as pos-
sible via a computer, tablet or smartphone.
Active comparator: TASK-Relax
TASK-Relax is a web-based self-guided relaxation
programme. Relaxation therapy is a commonly used
comparator in RCTs of CBT in psychiatry research
[25]. The TASK-Relax website consists of an introduc-
tory video, followed by five relaxation tasks: (i) audio-
and visually-guided breathing exercise, (ii) relaxing im-
agery and sounds, (iii) music for relaxation, (iv)
audio-guided progressive muscle relaxation and (v) a
selection of sounds of nature. All relaxation videos/au-
dios on the TASK-Relax website are also publically
available on YouTube. Participants allocated to TASK-
Relax receive instructions to try out all of the relax-
ation exercises, then select their favourite one(s) to
practice daily, for at least 5 min throughout their trial
participation.
Components common to both groups
Participants of both arms receive weekly mobile text re-
minder and a participant record card to record progress
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and completion of follow-up surveys. Data collection oc-
curs at T1(week 6) and T2 (week 20, primary endpoint)
via emailed links to self-completed electronic surveys.
Once the follow-up survey at T2 is complete, we offer
all participants access to the website given to the other
group for a further 10 weeks.
Concomitant care and interventions
Concomitant standard clinical care and interventions
(pharmacological or non-pharmacological) for anxiety or
mood disorders, e.g. antidepressants, benzodiazepines
are permitted and recorded in our follow-up surveys.
Randomisation and allocation concealment
A member of the research staff not involved in con-
ducting the TASK trial generates a permuted block
randomisation sequence with random block sizes
using STATA14 [26]. The sequence is uploaded to
the in-built randomisation module within REDCap,
which is inaccessible to the TASK researcher enrol-
ling participants. Once baseline data collection is
complete, the TASK researcher randomises the par-
ticipant and emails him/her the allocated treatment
website address and login details. Participants receive
telephone instructions on commencing the allocated
treatment. Participants allocated to TASK-CBT also
Fig. 3 TASK-CBT content
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receive an appointment for their first telephone
session.
Masking
The TASK researcher (HYC) enrolling participants and de-
livering the allocated intervention is not blinded to the
treatment group assignment. The TASK researcher informs
participants that they will be randomly allocated to one of
two anxiety interventions by the computer and receive the
login details to their allocated website via email. Partici-
pants are masked to the contents and type of anxiety inter-
vention allocated to the other group. This method attempts
to mask participants to our hypothesis that one treatment
is superior to the other.
Sub study of using a smartwatch to measure actigraphy
continuously
In a sub study embedded within the TASK trial, all
TASK participants are invited to wear the actigraph
smartwatch. Once consented, the smartwatch is posted
to the participant with simple care instructions. At
2 months, the battery of the smartwatch will run out.
With the participant’s agreement and on the safe return
of the first smartwatch, a second smartwatch will be sent
to the participant, so he/she can wear it for the rest of
the trial. All smartwatches are returned using prepaid
special delivery envelopes.
Feasibility outcomes
The current trial assesses the feasibility of the TASK-CBT
intervention and the technology-enabled trial procedures.
Feasibility data collected: recruitment (number per month),
percentage of completed consent (online or by post), time
taken to complete remote eligibility confirmation via elec-
tronic health records (date of randomisation–date of ‘Sign
Up and Consent Form’ received), percentage drop out after
fewer than three telephone TASK-CBT sessions and
self-completion of electronic follow-up surveys at T1 and
T2 (percentage of completed surveys).
We define a lack of feasibility of TASK-CBT and the
current trial design as (1) recruitment number of < 2
per month, (2) > 50% of TASK-CBT patients dropping
out after fewer than three telephone sessions, (3) > 10%
non-completion of follow up surveys at T2 and (4) par-
ticipants reporting harm from the intervention.
Treatment relevant outcomes (Table 1) include the modi-
fied Rankin Scale for dependence [27], EuroQol-5D5L [28],
7-item generalised anxiety disorder [23], modified fear
questionnaire (FQ) [3, 29], Patient Health Questionnaire-2
(PHQ-2) [30] and a single question to elicit concurrent
treatment for mood or anxiety. A user feedback survey
automatically follows the T2 follow-up survey.
Feasibility outcomes of the smartwatch sub study
We will assess the percentage of TASK participants who
also consent to wearing the smartwatch, the duration of
the smartwatch being worn by each participant using
the data recorded on the smartwatch, percentage of par-
ticipants of this sub study who agree to wear the smart-
watch again after 2 months, percentage of participants
who did not return smartwatch (attrition).
Assessing intervention fidelity and quality monitoring of
therapist
The therapist for this feasibility trial is a stroke physician
(HYC) who has received training on delivering CBT from
Table 1 Treatment relevant outcomes
T0 Baseline (pre-randomisation) T1 follow-up (~ week 6) T2 follow-up primary endpoint (~ week 20)
Demographics *
Diagnosis (stroke or TIA) *
Past history of anxiety or depression *
Medications for anxiety or mood *
mRS * * *
EQ5D5L-VAS * * *
GAD-7 * * *
PHQ-2 * * *
Modified FQ * * *
Single question on concurrent treatment for
mood or anxiety (drug or non-drug)
* * *
User feedback survey *
Sub study of wearing a smartwatch
Smartwatch for measuring rest/activity Continuous monitoring throughout the trial from T0 to T2
mRS modified Rankin Scale, EQ5D5L-VAS EuroQol-5D5L-Visual analogue score, GAD-7 7-item generalised anxiety disorder questionnaire, PHQ-2 2-item Patient
Health Questionnaire, FQ fear questionnaire
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and has ongoing supervision by a consultant neuropsych-
iatrist (AJC) at weekly meetings during the TASK trial. For
intervention fidelity, we will assess (i) percentage agree-
ment between the therapist’s record and transcripts of
audio-recording of telephone sessions, assessed by a clin-
ician independent of the study; (ii) automated data capture
of online task completion; (iii) summary web usage data
from Google Analytics.
Strategies to improve adherence in both arms
We post a participant record card to every participant and
send weekly text reminders to their mobile phone
throughout their participation. All participants will receive
text and email reminders to complete the follow-up sur-
veys at T1 and T2. Non-responders will receive further
text and email reminders and a final phone call from a re-
searcher blinded to the treatment allocation to complete
unfilled online surveys over the telephone.
Discontinuation criteria
Participants are free to withdraw from the study at any
point, or a participant can be withdrawn by one of the
TASK trial investigators if he/she loses capacity during
the study period.
Safety protocol
A trained medical doctor delivers the TASK-CBT inter-
vention in the current feasibility trial. All participants
have contact details of the TASK research team from the
start of the trial. They are informed that if severe cases
of anxiety or depression are identified during the trial,
the TASK research team will liaise with their general
practitioner to arrange appropriate care. Trial investiga-
tors will assess these cases and report as adverse events
to the sponsor according to good clinical practice.
Data management
All study data are collected and managed using REDCap
electronic data capture tools hosted at University of Ed-
inburgh. REDCap (Research Electronic Data Capture) is
a secure, web-based application designed to support data
capture for research studies [20]. Identifiable data are
only accessible by the TASK trial investigators and man-
aging team of the REDCap database. Anonymised data
from all smartwatch devices will be downloaded as bin-
ary files and sent to our collaborating data scientist at
the Centre for Medical Informatics, Usher Institute,
University of Edinburgh for analysis.
Data monitoring body
There is no data monitoring committee planned for this
study.
Statistical analyses and power calculation
As this is a feasibility study, we did not perform power
calculation. Feasibility outcomes will be summarised de-
scriptively. All electronic items on the follow-up surveys
must be scored to permit submission, preventing any
missing values. Only the trial investigators have access
to the final trial dataset. Actigraphy data from the smart-
watch device will be sent anonymously for time-series
analysis at the Centre for Medical Informatics, Usher In-
stitute, University of Edinburgh.
Discussion
Using innovative information technology, we designed a
streamlined web-enabled trial to be tested for the first
time in stroke and TIA patients: online self-screening
and recruitment, remote eligibility confirmation, elec-
tronic informed consent, remote intervention delivery,
automated self-reported outcome measures and data
capture of intervention fidelity. Our trial design offers a
number of potential advantages. For instance, a centra-
lised model could enable recruitment of eligible patients
anywhere in the country, or anywhere in the world with-
out the need to have locally-based principal investigators
or research staff. Larger sample sizes could be reached
more easily without significantly raising extra costs. Po-
tential participants with proof of identity and eligibility
could sign up themselves regardless of their locations.
This model of recruitment could empower patients to
choose to participate in a clinical trial without being
screened or ‘selected’ by local healthcare or research
staff. Generalisability could be increased as a result.
While this method of recruitment remains aspirational
for clinical trialists at present, owing to the regulatory
and administrative challenges in conducting multicentre
RCTs, it is of vital importance that we continue to evalu-
ate the feasibility of novel procedures that would in-
crease the ease of recruiting participants to large-scale
RCTs, regardless of where they live. A centralised system
of intervention delivery could be easily scaled up but
also quality assured—a particular challenge in clinical
trials where many therapists are employed to deliver the
intervention in different centres.
There has been limited use of wearable devices to as-
sess therapeutic outcomes in RCTs in stroke patients
and RCTs of psychological interventions [17]. We re-
cently observed high levels of avoidant behaviour across
a range of situations, e.g. going out alone, physical exer-
tion and social situations in people experiencing anxiety
after mild stroke and TIA [3]. An actigraph smartwatch
that records continuous data on activity/rest throughout
the entire RCT offers an easily scalable way of collecting
objective measures in large clinical trials with minimal
patient effort. This study will inform whether using
smartwatches could reduce attrition in RCTs, thus
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reducing bias in trial results and avoiding waste of valu-
able research resources.
Improving access to psychological therapy via a
centralised model of delivery
Anxiety is one of the commonest neuropsychiatric complica-
tions post stroke or TIA. Psychological care post stroke/TIA
is inadequate, and the traditional paradigm of delivering
face-to-face CBT at clinic is not feasible for the large popula-
tion of stroke and TIA patients owing to limited resources
and other barriers related to anxiety after stroke, e.g. agora-
phobia and social phobia. Innovative ways of delivering psy-
chological intervention remotely to the patient’s home, e.g.
individualised CBT via telemedicine could be a feasible
model to treat the large population of stroke and TIA pa-
tients experiencing anxiety. If feasible, the TASK-CBT inter-
vention could provide an exemplar model for delivering
psychological intervention for a range of post-stroke psycho-
logical complications. Web-enabled features embedded in
our TASK-CBT and TASK-Relax websites, e.g. data capture
of completion of weekly online tasks and web usage analyt-
ics, provide novel ways of measuring intervention fidelity ob-
jectively—an important aspect of internal validity that can be
challenging to assess and is infrequently reported in trials of
complex intervention [31].
The TASK trial design has the potential to be applied in
RCTs of any self-management or guided self-management
interventions for a range of patient groups. Our design
has the obvious limitation of excluding people who have
no access to the internet, or those who do not have a
minimum level of skills in information technology. This is
likely to be overcome by the trend towards wider adoption
of home broadband and user-friendly devices amongst se-
niors [32], and the encouragement and assistance pro-
vided by family members.
Considerations for the next phase, TASK II RCT
The current trial represents feasibility testing of the
TASK-CBT intervention and the technology-enabled
trial procedures. This will lead to further refinements of
intervention design and trial procedures. Our current
trial does not inform the efficacy of TASK-CBT. A num-
ber of important aspects of the TASK trial design will
need to be considered in the next phase, the TASK II
trial, before proceeding to the definitive trial, TASK III.
Choice of primary outcome
In TASK II, we will determine an appropriate primary out-
come measure to be used in the definitive trial. We will
consider a range of candidate outcome measures of anxiety,
functional independence, quality of life and participation.
We will select the primary outcome based on the measure’s
sensitivity to change/difference between groups, its practi-
cality for use in large-scale RCT (to minimise attrition) and
its clinical meaningfulness. Our observational data sug-
gested that stroke/TIA patients with anxiety disorder re-
ported a statistically significantly higher level of functional
dependence on the modified Rankin Scale, a poorer quality
of life on EurolQol-5D-5L and worse participation on a the
Work and Social Adjustment Scale, compared to those
without anxiety [3].
Patients after stroke/TIA can present, to varying de-
gree, predominantly phobic, predominantly generalised,
or mixed anxiety types. This poses an additional chal-
lenge as different anxiety measures are required to assess
the two anxiety subtypes. It may be necessary to have
different primary outcomes defined for different anxiety
subtypes.
Other considerations include defining the responder’s
status: for example, whether to use the minimal rele-
vant change from baseline on an anxiety measure, a
dichotomised outcome, or an absolute anxiety level
post-intervention to assess between-group difference.
Choice of comparator
Our choice of using TASK-Relax, a web-guided relaxation
programme as an active control was to avoid exaggerating
the effect size—a known effect of using ‘waitlist’ or ‘treat-
ment as usual’ as control condition in RCTs of psycho-
logical interventions [33]. We accept that TASK-Relax
could have an effect on anxiety in the short-term, but our
hypothesis is that TASK-CBT will have a long-term effect
while TASK-Relax would not (at week 20). TASK II will
provide information on the outcome measure and vari-
ability in the two groups, informing the minimally import-
ant difference for our power calculations.
TASK intervention design
We will refine the TASK-CBT intervention based on
participants’ feedback from this current trial. The
TASK therapist training materials will be developed
based on our experience and the use of anonymised
audio-recording transcripts. We will consider using
audio recording for within-trial training, maintenance
and enhancement of intervention fidelity in the next
phase of TASK, where therapists will be employed to
deliver the TASK-CBT intervention.
Cost effectiveness
As it is not yet clear whether TASK-CBT is cost-effective
in stroke and TIA patients, health economics analysis of
the TASK-CBT intervention using EuroQoL-5D-5L data
will be conducted in the definitive RCT.
Efficient large-scale RCT using web-enabled procedures
Testing the feasibility of self-recruitment and remote eli-
gibility confirmation in our local centre represents only
the first step in finding novel efficient ways of recruiting
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patients to large-scale nationwide RCTs. We believe all
patients should be empowered to self-recruit to an RCT
that they are eligible to regardless of where they live.
Verifying eligibility remotely using electronic health re-
cords across different health boards in RCTs could be a
viable option in the future but at present remains aspir-
ational due to administrative barriers.
Trial status
Protocol version: AC17087 version 3, 1/12/2017.
Recruitment commenced on 17/1/2018. Estimated
completion date 1/5/2018.
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